Dabigatran aggravates topoisomerase I peptide-loaded dendritic cells-induced lung and skin fibrosis

Clinical and Experimental Rheumatology

Volumn 35, Issue , 2017, Pages S35-S39

  Mehta, Heena ^a   Mashiko, Shunya ^a   Goulet, Philippe Olivier ^a   Desjardins, Jade ^a   Pérez, Gemma ^a   Koenig, Martial ^a   Senécal, Jean Luc ^a   Sarfati, Marika ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Animal models; Fibrosis; Inflammation; Systemic sclerosis; Thrombin

Indexed keywords

DABIGATRAN ETEXILATE; DNA TOPOISOMERASE; THROMBIN; ANTITHROMBIN; DABIGATRAN; TOP1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DENDRITIC CELL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL MODEL; GENE EXPRESSION; IMMUNIZATION; INFLAMMATION; LUNG FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; ANIMAL; FEMALE; FIBROSIS; IMMUNOLOGY; MALE; PATHOLOGY; SKIN;

ANIMALS; ANTITHROMBINS; DABIGATRAN; DENDRITIC CELLS; DNA TOPOISOMERASES, TYPE I; FEMALE; FIBROSIS; MALE; MICE; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC; SKIN;

EID: 85031690894     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. LUDWICKA-BRADLEY A, SILVER RM, BOGATKEVICH GS: Coagulation and autoimmunity in scleroderma interstitial lung disease. Semin Arthritis Rheum 2011; 41: 212-22
2. OHBA T, McDONALD JK, SILVER RM, STRANGE C, LeROY EC, LUDWICKA A: Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor. Am J Respir Cell Mol Biol 1994; 10: 405-12
3. BOGATKEVICH GS, LUDWICKA-BRADLEY A, SILVER RM: Dabigatran, a direct thrombin inhibitor, blocks differentiation of normal fibroblasts to a myofibroblast phenotype and demonstrates anti-fibrotic effects on scleroderma lung fibroblasts. Arthritis Rheum 2009; 60: 3455-64
4. BOGATKEVICH GS, LUDWICKA-BRADLEY A, NIETERT PJ, AKTER T, van RYN J, SILVER RM: Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. Arthritis Rheum 2011; 63: 1416-25
5. MEHTA H, GOULET PO, NGUYEN V et al.: Topoisomerase I peptide-loaded dendritic cells induce autoantibody response as well as skin and lung fibrosis. Autoimmunity 2016; 49: 503-13
6. SPARKENBAUGH EM, CHANTRATHAMMACHART P, MICKELSON J et al.: Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Blood 2014; 123: 1747-56
7. KAMISATO C, FURUGOHRI T, MORISHIMA Y: A direct thrombin inhibitor suppresses protein C activation and factor Va degradation in human plasma: Possible mechanisms of paradoxical enhancement of thrombin generation. Thrombosis Res 2016; 141: 77-83
8. MATTSSON C, MENSCHIK-LUNDIN A, NYLANDER S, GYZANDER E, DEINUM J: Effect of different types of thrombin inhibitors on thrombin/thrombomodulin modulated activation of protein C in vitro. Thrombosis Res 2001; 104: 475-86
9. HUSARI A, BEYDOUN A, SHEIK AMMAR A, MAAKARON JE, TAHER A: The untold story of Dabigatran etexilate: alveolar hemorrhage in an elderly patient with interstitial pulmonary fibrosis. J Thromb Thrombolysis 2013; 35: 81-2
10. SARGENT JL, LI Z, ALIPRANTIS AO et al.: Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics. Arthritis Rheumatol 2016; 68: 2003-15
11. KUROIWA K, ARAI T, OKAZAKI H, MINOTA S, TOMINAGA S: Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun 2001; 284: 1104-8
12. PATTANAIK D, BROWN M, POSTLETHWAITE BC, POSTLETHWAITE AE: Pathogenesis of systemic sclerosis. Front Immunol 2015; 6: 272
13. REININGER AJ: Function of von Willebrand factor in haemostasis and thrombosis. Haemophilia 2008; 14 (Suppl. 5): 11-26
14. RANKIN AL, MUMM JB, MURPHY E et al.: IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol 2010; 184: 1526-35
15. SILACCI P, DAYER JM, DESGEORGES A, PETER R, MANUEDDU C, GUERNE PA: Interleukin (IL)-6 and its soluble receptor induce TIMP-1 expression in synoviocytes and chondrocytes, and block IL-1-induced collagenolytic activity. J Biol Chem 1998; 273: 13625-9